Temozolomide has anti-tumor effects through the phosphorylation of cPLA2 on glioblastoma cells.

Abstract

Temozolomide is an alkylating agent used as the first line of treatment for glioblastoma. However, chemoresistance to temozolomide is common in glioma patients. In addition, there are likely many unknown mechanisms for the anti-tumor effects of temozolomide. It is known that an alkylating agent, sulfur mustard, activates cytosolic phospholipase A2 (cPLA₂) releasing arachidonic acid to suppress tumors. The present study was performed to elucidate the involvement of cPLA2 in the anti-tumor mechanisms of temozolomide. In three glioblastoma cell lines (GL261, U251MG and T98G), we performed several evaluations including cell viability, cell migration and apoptosis, to study temozolomide-induced anti-tumor effects. Further, we evaluated tumor size in the murine orthotropic glioblastoma model after oral administration of temozolomide. Finally, we investigated the phosphorylation of cPLA2 in GL261 cells treated with temozolomide, and clarified whether phosphorylation of cPLA2 affects cell growth. Temozolomide suppressed cell growth and cell migration in glioblastoma cells in vitro and showed anti-tumor effect in the murine orthotopic glioblastoma model in vivo. Furthermore, temozolomide increased phosphorylation of cPLA2, which was associated with suppression of cell growth. However, in MGMT high-expressing glioblastoma T98G cells, temozolomide could not suppress cell growth or cause phosphorylation of cPLA2. These findings indicate that temozolomide suppressed cell growth partly by phosphorylation of cPLA2 in glioblastoma cells. In addition, because temozolomide did not cause phosphorylation of cPLA2 in MGMT high-expressing glioblastoma T98G cells, phosphorylation of cPLA2 may be caused by DNA alkylation of temozolomide.

• Authors: Shohei Tsuji, Yuta Ohno, Shinsuke Nakamura, Tetsuya Yamada, Yasuhiro Noda, Masanao Saio, Toru Iwama, Masamitsu Shimazawa, Hideaki Hara
• Journal: Brain research (Brain Res) Vol. 1723 Pg. 146396 (11 15 2019) ISSN: 1872-6240 [Electronic] Netherlands
• PMID: 31442413 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 Elsevier B.V. All rights reserved.

Chemical References

• Phospholipases A2, Cytosolic
• Temozolomide

Topics

• Animals
• Apoptosis (drug effects)
• Brain Neoplasms (drug therapy, metabolism)
• Cell Line, Tumor
• Cell Proliferation (drug effects)
• Cell Survival (drug effects)
• Glioblastoma (drug therapy, metabolism)
• Humans
• Male
• Mice
• Mice, Inbred Strains
• Phospholipases A2, Cytosolic (metabolism)
• Phosphorylation (drug effects)
• Temozolomide (pharmacology)